JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
 
 

トップページ
バックナンバー
学会誌MR
NLリウマチ
メルマガ
旧和文誌
会員へのお知らせ
医療・医薬情報
リウマチ学会TV
住所・勤務先変更
Original Article

The relationships between titers of anti-Ro or anti-La as measured by ELISA and salivary production rate with age correction

Authors

Kunio Takada1, Kimihiro Suzuki1, Mitsuyo Matsumoto1, Makoto Okada1, Takashi Nakanishi1, Hideyuki Horikoshi1, Tomoaki Higuchi1, Akiyoshi Nakayama1 and Fumitaka Ohsuzu1

  1. Department of Internal Medicine, Division of Rheumatology, National Defense Medical College, 3-2 Namiki, Tokorozawa Saitama, 359-8513, Japan
Received:

15 February 2008

Accepted:

2 May 2008

Published online:

18 July 2008

Full Text

PDF

Abstract

The objective of this work was to clarify the clinical significance of titers of anti-Ro and anti-La, the relationships between titers of either anti-Ro or anti-La, and salivary production rate (SPR). These autoantibodies were titrated using enzyme-linked immunosorbent assay. The Saxon test was performed to measure SPR. Fifty-one females who had anti-Ro but not anticentromere antibodies or anti-U1RNP were enrolled. SPR decreased significantly with age. In order to exclude the effect of aging on SPR, we calculated the “SPR with age correction.” According to the results of a multiple regression analysis, only the anti-La titer was significantly associated with SPR with age correction. The distribution pattern of the anti-La titers consisted of two subgroups (with a titer index cutoff of 100.0): a negative anti-La titer (anti-La < 25.0) and low anti-La titer (25.0 ≤ anti-La < 100.0) group, and a high anti-La titer group (anti-La ≥ 100.0). The concentration of serum IgG and the frequency of Sjogren’s syndrome in the high anti-La titer group were significantly higher than those in the negative anti-La and low anti-La titer group. Several new aspects of the clinical significance of titrating anti-Ro and anti-La in comparison with SPR have been revealed.

Key words

Anti-Ro/SSA antibodies - Anti-La/SSB antibodies - Titer - Saliva - ELISA


Copyright Japan College of Rheumatology All rights reserved.